Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Pension (2016 - 2025)

Protalix BioTherapeutics has reported Pension over the past 16 years, most recently at $661000.0 for Q4 2025.

  • Quarterly results put Pension at $661000.0 for Q4 2025, up 18.25% from a year ago — trailing twelve months through Dec 2025 was $661000.0 (up 18.25% YoY), and the annual figure for FY2025 was $661000.0, up 18.25%.
  • Pension for Q4 2025 was $661000.0 at Protalix BioTherapeutics, up from $631000.0 in the prior quarter.
  • Over the last five years, Pension for PLX hit a ceiling of $2.5 million in Q1 2022 and a floor of $551000.0 in Q1 2025.
  • Median Pension over the past 5 years was $1.5 million (2023), compared with a mean of $1.4 million.
  • Biggest five-year swings in Pension: plummeted 56.52% in 2023 and later increased 18.25% in 2025.
  • Protalix BioTherapeutics' Pension stood at $2.5 million in 2021, then crashed by 33.58% to $1.6 million in 2022, then tumbled by 56.52% to $714000.0 in 2023, then decreased by 21.71% to $559000.0 in 2024, then grew by 18.25% to $661000.0 in 2025.
  • The last three reported values for Pension were $661000.0 (Q4 2025), $631000.0 (Q3 2025), and $615000.0 (Q2 2025) per Business Quant data.